3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
30
Burkitt Lymphoma
12
Lung Neoplasms
11
Leukemia, Myeloid, Acute
11
Recurrence
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma, Non-Hodgkin
7
Hodgkin Disease
7
Carcinoma, Non-Small-Cell Lung
7
Neuroblastoma
4
Lymphoma, B-Cell
4
Leukemia
4
Wilms Tumor
3
Sarcoma, Ewing
3
Plasmablastic Lymphoma
3
Neoplasms, Germ Cell and Embryonal
3
Neoplasms
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, T-Cell
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Immunoblastic Lymphadenopathy
3
Ganglioneuroblastoma
3
Teratoma
2
Sarcoma
2
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
LY3023414
2
talazoparib
1
olaparib
1
irinotecan sucrosofate
1
amino-acid, glucose, and electrolyte solution
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Liquid Biopsy
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Etoposide
×
90 days
×
Clear all
No trials found.